UNSPSC 51241700: Combination contact lens solutions

This classification denotes combination drugs and preparations that consist of sterile solutions to clean and/or disinfect contact lenses. Typical combination contact lens solution constituents are benzalkonium chloride, boric acid, chlorhexidine, edta, hydroxyethyl cellulose, polyvinyl alcohol, and sodium chloride.

UNSPSC 51241700 Combination contact lens solutions is a Class code that in recent state and local procurement activity covers generic multi-source pharmaceuticals and over-the-counter products distributed across participating government facilities. The scope extends beyond the nominal code description to encompass manufacturers supplying comprehensive product lines with detailed specifications including National Drug Codes, SKUs, UPCs, generic descriptions, strength, dosage form, trade names, packaging configurations, and manufacturing locations. Products must meet FDA requirements, comply with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), and maintain expiration dates of at least one year from manufacture with a minimum six-month shelf life. Vendors must establish contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, Morris & Dickson Co., LLC) and support chargeback systems and EDI capabilities. The purchasing base comprises state procurement offices and cooperative purchasing alliances administering contracts across multiple state and local government facilities, including health systems, correctional institutions, and other public agencies.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued the most recent representative opportunity — a Request for Proposal (RFP) for generic multi-source pharmaceuticals and OTC products with a due date of March 26, 2026, and anticipated contract effectiveness of July 1, 2026. The alliance serves participating jurisdictions across Minnesota and Oregon. Evaluation weights price competitiveness at 75 percent, fixed pricing at 10 percent, and administrative compliance including EDI capability and chargeback system readiness at the remaining 15 percent. Vendors must carry comprehensive insurance including $5 million commercial general liability, $2 million network security and privacy liability, and $2 million professional liability. The contract structure allows for sole, dual, or multi-awards based on therapeutic considerations and member-specific needs, with initial two-year terms and optional extensions through June 30, 2028 for incumbent responders. No specific budget range or award value is disclosed in the solicitation materials.